Literature DB >> 4393524

The role of immunoblasts in host resistance and immunotherapy of primary sarcomata.

P Alexander, J G Hall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4393524     DOI： 10.1016/s0065-230x(08)60162-1

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN： 0065-230X            Impact factor:   6.242


× No keyword cloud information.
  12 in total

1.  Contact sensitivity in the mouse. X. Non-specific cytotoxicity of T blasts in the draining lymph nodes.

Authors:  G L Asherson; J Ferluga
Journal:  Immunology       Date:  1973-09       Impact factor: 7.397

Review 2.  Evidence for antigenicity in human tumours with reference to both melanoma and acute leukaemia.

Authors:  G H Fairley
Journal:  Br Med J       Date:  1970-11-21

3.  Kinetic studies of circulating lymphocytes in malignant lymphatic disease using the impulse cytophotometer.

Authors:  F J Cleton; L A Smets; H Van Rooy; A M Boogaards
Journal:  Br J Cancer Suppl       Date:  1975-03

4.  The spread of cancer in the organism. Facts and problems.

Authors:  P Sträuli
Journal:  Naturwissenschaften       Date:  1977-08

Review 5.  Relationship of tumor leucocytic infiltration to host defense mechanisms and prognosis.

Authors:  J W Kreider; G L Bartlett; B L Butkiewicz
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

6.  Cyclic AMP reduces and cyclic GMP increases the traffic of lymphocytes through peripheral lymph nodes of sheep in vivo.

Authors:  T C Moore; P J Lachmann
Journal:  Immunology       Date:  1982-11       Impact factor: 7.397

Review 7.  Transfer of tumor specific immunity with "immune" RNA: prospects for the treatment of human cancer.

Authors:  D Fritze; D H Kern; Y H Pilch
Journal:  Klin Wochenschr       Date:  1976-09-15

8.  Studies on FeSV induced sarcomata in sheep with particular reference to the regional lymphatic system.

Authors:  J G Hall; R G Scollay; M S Birbeck; G H Theilen
Journal:  Br J Cancer       Date:  1975-12       Impact factor: 7.640

9.  Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient.

Authors:  R L Powles; J Russell; T A Lister; T Oliver; J M Whitehouse; J Malpas; B Chapuis; D Crowther; P Alexander
Journal:  Br J Cancer       Date:  1977-03       Impact factor: 7.640

10.  Mechanism by which antibodies to non-AgB antigens mediate rejection of rat leukaemia cells.

Authors:  S Denham; J W Hooton; R K Barfoot; P Alexander; R Mayol; A B Wrathmell
Journal:  Br J Cancer       Date:  1980-09       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.